Evidence map›Paper›PMID 34422150›Full record

ArticleRadiology case reports2021

A case of a patient with neurofibromatosis type I who developed pneumothorax and eosinophilic pleural effusion after suffering from COVID-19 pneumonia.

Ikuo Wakamatsu, Masakiyo Yatomi, Shogo Uno, Yuko Oishi, Hidekazu Ikeuchi, Chiharu Hanazato, Yuri Sawada, Haruka Saito, Koichi Yamaguchi, Norimitsu Kasahara and 8 more

Erratum issuedOpen access · goldAbstract readCase Reports
In one paragraph

Article in Radiology case reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.7field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

18 authors at 2 institutions in 1 country.

Ikuo WakamatsuDivision of Allergy and Respiratory Medicine, Integrative Center of Internal Medicine, Gunma University Hospital, Maebashi, Gunma, Japan.
Masakiyo YatomiDivision of Allergy and Respiratory Medicine, Integrative Center of Internal Medicine, Gunma University Hospital, Maebashi, Gunma, Japan.
Shogo UnoDivision of Allergy and Respiratory Medicine, Integrative Center of Internal Medicine, Gunma University Hospital, Maebashi, Gunma, Japan.
Yuko OishiDivision of Nephrology and Rheumatology, Integrative Center of Internal Medicine, Gunma University Hospital, Maebashi, Gunma, Japan.
Hidekazu IkeuchiDivision of Nephrology and Rheumatology, Integrative Center of Internal Medicine, Gunma University Hospital, Maebashi, Gunma, Japan.
Chiharu HanazatoDivision of Allergy and Respiratory Medicine, Integrative Center of Internal Medicine, Gunma University Hospital, Maebashi, Gunma, Japan.
Yuri SawadaDivision of Allergy and Respiratory Medicine, Integrative Center of Internal Medicine, Gunma University Hospital, Maebashi, Gunma, Japan.
Haruka SaitoDivision of Allergy and Respiratory Medicine, Integrative Center of Internal Medicine, Gunma University Hospital, Maebashi, Gunma, Japan.
Koichi YamaguchiDivision of Allergy and Respiratory Medicine, Integrative Center of Internal Medicine, Gunma University Hospital, Maebashi, Gunma, Japan.
Norimitsu KasaharaInnovative Medical Research Center, Gunma University Hospital, Maebashi, Gunma, Japan.
Yosuke MiuraDivision of Allergy and Respiratory Medicine, Integrative Center of Internal Medicine, Gunma University Hospital, Maebashi, Gunma, Japan.
Hiroaki TsurumakiDivision of Allergy and Respiratory Medicine, Integrative Center of Internal Medicine, Gunma University Hospital, Maebashi, Gunma, Japan.
Kenichiro HaraDivision of Allergy and Respiratory Medicine, Integrative Center of Internal Medicine, Gunma University Hospital, Maebashi, Gunma, Japan.
Yasuhiko KogaDivision of Allergy and Respiratory Medicine, Integrative Center of Internal Medicine, Gunma University Hospital, Maebashi, Gunma, Japan.
Noriaki SunagaDivision of Allergy and Respiratory Medicine, Integrative Center of Internal Medicine, Gunma University Hospital, Maebashi, Gunma, Japan.
Takeshi HisadaGunma University Graduate School of Health Sciences, Maebashi, Gunma, Japan.
Keiju HiromuraDivision of Nephrology and Rheumatology, Integrative Center of Internal Medicine, Gunma University Hospital, Maebashi, Gunma, Japan.
Toshitaka MaenoDivision of Allergy and Respiratory Medicine, Integrative Center of Internal Medicine, Gunma University Hospital, Maebashi, Gunma, Japan.
Gunma University Hospital · JPGunma University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Coronavirus disease 2019 (COVID-19) has become a global pandemic since its discovery in December 2019, and as the disease continues to evolve, varying complications associated with it continue to arise. In this regard, computed tomography has played an extremely important role in the diagnosis and evaluation of COVID-19 pneumonia and its complications. We encountered a case of a male patient with neurofibromatosis (type I) who developed concurrent pneumothorax and pleural effusion during his recovery period from severe COVID-19 pneumonia. Pulmonary fibrosis and emphysema were also confirmed. Furthermore, an eosinophil pleural effusion appeared and was prolonged during the healing process of COVID-19. This clinical presentation suggests that fibrosis and emphysema formation due to neurofibromatosis may have caused pneumothorax and pleural effusion.

Indexed as

computed tomography (CT)Coronavirus disease 2019 (COVID-19)eosinophilic pleural effusionneurofibromatosispneumothorax

Identifiers

PMID34422150
PMCPMC8367777
OpenAlexW3193362660

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.